These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2190782)
21. Chloride modulation of insulin release, 86Rb+ efflux, and 45Ca2+ fluxes in rat islets stimulated by various secretagogues. Tamagawa T; Henquin JC Diabetes; 1983 May; 32(5):416-23. PubMed ID: 6341124 [TBL] [Abstract][Full Text] [Related]
22. Islet cell surface antibodies in diabetes and their possible influence on glucose tolerance. Ohgawara H; Hirata Y Tohoku J Exp Med; 1984 Feb; 142(2):211-6. PubMed ID: 6372161 [TBL] [Abstract][Full Text] [Related]
23. Pancreatic islet cells in tissue culture: function and immunoreactivity with serum autoantibodies from diabetes type-1 patients and monoclonal antibodies ICA-1. Zlobina EN; Rossels AN; Yesenin VI; Demin YM; Bachurin PS; Filatov AV; Brikova SV Exp Clin Endocrinol; 1989 May; 93(2-3):161-5. PubMed ID: 2673809 [TBL] [Abstract][Full Text] [Related]
24. Increased preproinsulin mRNA in pancreatic islets incubated with islet cell-stimulating antibodies from serums of type I diabetic patients. Foggensteiner L; Bone AJ; Webster KA; Wilkin TJ Diabetes; 1990 Oct; 39(10):1165-9. PubMed ID: 2210069 [TBL] [Abstract][Full Text] [Related]
25. A novel microwell indirect immunofluorescence assay to detect antibodies against islet cell surface antigens in insulin-dependent diabetes mellitus. Matsuba I; Lernmark A Reg Immunol; 1990; 3(1):23-8. PubMed ID: 2223554 [TBL] [Abstract][Full Text] [Related]
26. Relationship of islet cell and islet cell surface antibodies to the presentation and early course of IDDM in childhood. Daneman D; Sochett E; Pak CY; Yoon JW Diabetes Res Clin Pract; 1988 Jan; 4(2):127-32. PubMed ID: 3277828 [TBL] [Abstract][Full Text] [Related]
27. The frequency of islet cell surface antibodies in newly diagnosed diabetics from Ethiopia. Peters WH; Lester FT; Kohnert KD; Hildmann W Exp Clin Endocrinol; 1986 Aug; 87(3):326-32. PubMed ID: 3536536 [TBL] [Abstract][Full Text] [Related]
28. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN). Ammon HP Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):251-64. PubMed ID: 241943 [TBL] [Abstract][Full Text] [Related]
29. Adult human pancreatic islet cells in tissue culture: function and immunoreactivity. Campbell IL; Colman PG; Harrison LC J Clin Endocrinol Metab; 1985 Oct; 61(4):681-5. PubMed ID: 2863282 [TBL] [Abstract][Full Text] [Related]
30. Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Henquin JC Diabetologia; 1980; 18(2):151-60. PubMed ID: 6988275 [TBL] [Abstract][Full Text] [Related]
31. Preferential lysis of pancreatic B-cells by islet cell surface antibodies. Dobersen MJ; Scharff JE Diabetes; 1982 May; 31(5 Pt 1):459-62. PubMed ID: 6759262 [TBL] [Abstract][Full Text] [Related]
32. Islet cell surface antibodies are more common in patients and relatives in areas and during seasons with high incidence of insulin-dependent diabetes mellitus. Samuelsson U; Ludvigsson J; Bottazzo GF; Adolfsson S; Cacciari E; Chiumello G; Deschamps I; Francois R; Kaprio E; Schober E; Weber B Pediatr Res; 1996 Nov; 40(5):695-701. PubMed ID: 8910934 [TBL] [Abstract][Full Text] [Related]
33. Chronic perifusion of rat islets with palmitate suppresses glucose-stimulated insulin release. Elks ML Endocrinology; 1993 Jul; 133(1):208-14. PubMed ID: 8319569 [TBL] [Abstract][Full Text] [Related]
34. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729 [TBL] [Abstract][Full Text] [Related]
35. Oscillations in cytoplasmic free calcium concentration in human pancreatic islets from subjects with normal and impaired glucose tolerance. Kindmark H; Köhler M; Arkhammar P; Efendic S; Larsson O; Linder S; Nilsson T; Berggren PO Diabetologia; 1994 Nov; 37(11):1121-31. PubMed ID: 7867884 [TBL] [Abstract][Full Text] [Related]
36. Glucose insensitivity and amino-acid hypersensitivity of insulin release in rats with non-insulin-dependent diabetes. A study with the perfused pancreas. Giroix MH; Portha B; Kergoat M; Bailbe D; Picon L Diabetes; 1983 May; 32(5):445-51. PubMed ID: 6341128 [TBL] [Abstract][Full Text] [Related]
37. Effects of drugs on glucose and tolbutamide-stimulated insulin release from isolated rat islets of Langerhans. El-Denshary EE; Montague W Biochem Pharmacol; 1976 Jul; 25(13):1451-4. PubMed ID: 782457 [No Abstract] [Full Text] [Related]
38. Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells. Van De Winkel M; Smets G; Gepts W; Pipeleers D J Clin Invest; 1982 Jul; 70(1):41-9. PubMed ID: 6123526 [TBL] [Abstract][Full Text] [Related]
39. Impaired coupling of glucose signal to the exocytotic machinery in diabetic GK rats: a defect ameliorated by cAMP. Abdel-Halim SM; Guenifi A; Khan A; Larsson O; Berggren PO; Ostenson CG; Efendić S Diabetes; 1996 Jul; 45(7):934-40. PubMed ID: 8666145 [TBL] [Abstract][Full Text] [Related]
40. Interactions between vitamin E and glucose on B-cell functions in the rat: an in vivo and in vitro study. Tajiri Y; Grill VE Pancreas; 1999 Apr; 18(3):274-81. PubMed ID: 10206486 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]